Skip to main content

Table 1 Characteristics of breast cancer survivors included in this study

From: Prevalence of metabolic syndrome among breast cancer survivors in East Coast of Peninsular Malaysia

Characteristics Total (n = 95) MetS (n = 48) Non-MetS (N = 47) p
Sociodemographic profiles
Age a 53.7 (7.6) 55.1 (7.9) 52.4 (7.2) 0.082
Ethnic
 Malay 88 (92.6) 45 (93.8) 43 (91.5) 0.714
 Chinese 7 (7.4) 3 (6.3) 4 (8.5)  
Marital status
 Single 3 (3.2) 0 (0) 3 (6.4) 0.262
 Married 74 (77.9) 37 (77.1) 37 (78.7)  
 Divorced 2 (2.1) 1 (2.1) 1 (2.1)  
 Others 16 (16.8) 10 (20.8) 6 (12.8)  
Education
 Primary 6 (6.3) 2 (4.2) 4 (8.5) 0.214
 Secondary 61 (64.2) 34 (70.8) 27 (57.4)  
 Tertiary 28 (29.5) 12 (25.0) 16 (34.0)  
Occupation
 Professional 22 (23.2) 8 (16.7) 14 (29.8) 0.106
 Support staff 10 (10.5) 6 (12.5) 4 (8.5)  
 Self-employed 17 (17.9) 13 (27.1) 4 (8.5)  
 Housewife 33 (34.7) 14 (29.2) 19 (40.4)  
 Pensioner 13 (13.7) 7 (14.6) 6 (12.8)  
Household income b
  < MYR 1000 35 (36.8) 20 (41.7) 15 (31.9) 0.450
 MYR 1000–3000 31 (32.6) 16 (33.3) 15 (31.9)  
  > MYR 3000 29 (30.5) 12 (25.0) 17 (36.2)  
Menopausal status
 Premenopausal 12 (12.6) 5 (10.4) 7 (14.9) 0.511
 Postmenopausal 83 (87.4) 43 (89.6) 40 (85.1)  
Breastfeeding
 Yes 84 (88.4) 44 (91.7) 40 (85.1) 0.318
 No 11 (11.6) 4 (8.3) 7 (14.9)  
Oral contraceptive pills
 Yes 43 (45.3) 19 (39.6) 24 (51.1) 0.261
 No 52 (54.7) 29 (60.4) 23 (48.9)  
Hormone replacement therapy
 Yes 16 (16.8) 6 (12.5) 10 (21.3) 0.253
 No 79 (83.2) 42 (87.5) 37 (78.7)  
Family history of breast cancer
 Yes 26 (27.4) 14 (29.2) 12 (25.5) 0.691
 No 69 (72.6) 34 (70.8) 35 (74.5)  
Clinical and metabolic profiles
Cancer stages
 I 15 (15.8) 7 (14.6) 8 (17.0) 0.019*
 II 55 (57.9) 34 (70.8) 21 (44.7)  
 III 25 (26.3) 7 (14.6) 18 (38.3)  
Cancer duration (years) a 6.65 (4.19) 7.23 (5.22) 6.06 (2.71) 0.177
Treatments
 Surgery c 94 (98.9) 48 (100) 46 (97.9) 0.495
 Chemotherapy 95 (100) 48 (100) 47 (100)
 Radiotherapy 86 (90.5) 41 (85.4) 45 (95.7) 0.086
Comorbidities e
 Diabetes 17 (17.9) 13 (27.1) 4 (8.5) 0.018*
 Hypertension 21 (22.1) 15 (31.3) 6 (12.8) 0.030*
 Heart disease c 2 (2.1) 1 (2.1) 1 (2.1) 1.000
Metabolic profiles d
 Total cholesterol (mmol/L) 6.1 (1.6) 6.0 (1.4) 6.2 (1.6) 0.250
 LDL-c (mmol/L) 3.8 (1.5) 3.7 (1.3) 4.0 (1.6) 0.195
 HDL-c (mmol/L) 1.4 (0.4) 1.3 (0.4) 1.5 (0.5) < 0.001*
 TG (mmol/L) 1.5 (0.8) 1.8 (0.9) 1.3 (0.6) < 0.001*
 FBG (mmol/L) 5.7 (1.9) 6.5 (3.0) 5.0 (0.9) < 0.001*
 Systolic BP (mmHg) 128 (19) 134 (25) 124 (12) 0.006*
 Diastolic BP (mmHg) 79 (13) 80 (13) 78 (11) 0.020*
Anthropometric profiles
Weight (kg) a 66.0 (12.4) 68.7 (10.0) 63.3 (14.0) 0.032*
Height (cm) a 153.9 (6.0) 154.1 (5.1) 153.6 (6.9) 0.711
Waist circumference (cm) a 88.8 (11.7) 92.2 (9.9) 85.3 (12.4) 0.003*
Body fat percentage (%) e 39.0 (6.9) 40.5 (7.7) 38.2 (8.0) 0.020*
BMI (kg/m2) a 27.9 (4.9) 29.0 (4.3) 26.7 (5.2) 0.023*
BMI classification (kg/m2) c
 Underweight 3 (3.2) 0 (0) 3 (6.4) 0.138
 Normal 20 (21.1) 8 (16.7) 12 (25.5)  
 Overweight 43 (45.3) 22 (45.8) 21 (44.7)  
 Obese 29 (30.5) 18 (37.5) 11 (23.4)  
  1. Data in number (%), p-value derived using Chi-square test
  2. aData in mean (SD), p-value derived using Independent t-test
  3. bMYR, Malaysian Ringgit; MYR 1000 is equal to USD 242
  4. cData in number (%), p-value derived using Fisher’s Exact test
  5. dData in median (IQR), p-value derived using Mann-Whitney test
  6. eThe number of subjects without these comorbidities and complications were not reported in this table
  7. *p < 0.05, significantly different
  8. BMI Body mass index, BP Blood pressure, FBG Fasting blood glucose, HDL-c High density lipoprotein cholesterol, LDL-c Low density lipoprotein cholesterol, MetS Metabolic syndrome, TG Triglyceride